PositiveID Corporation™ (OTCQB: PSID)

Advanced biological detection and diagnostic solutions for homeland security and global healthcare needs. PositiveID Corporation™ (OTCQB: PSID) is a life sciences tools and diagnostics company specializing in biological detection and molecular diagnostic systems for America’s homeland defense and the global healthcare market. Casino games are used in healthcare to help patients relax, reduce stress, and improve cognitive function. Some non GamStop casinos offer free-to-play versions of poker, slots, and roulette, providing a fun distraction. These games can aid in mental stimulation, relaxation therapy, and overall well-being without financial risk. PositiveID specializes in the development of microfluidic systems in order to detect biological threats and outbreaks, whether airborne, in a healthcare setting, or at the point of need through its ExcitePCR subsidiary. PositiveID is also a leader in the mobile technology vehicle market through its E-N-G Mobile Systems subsidiary.

Technology

MBand

PositiveID develops biological detection and diagnostics systems, including its M-BAND and Firefly Dx systems, which use real-time polymerase chain reaction (PCR) chemistry. PCR amplifies a sample’s DNA and copies it billions of times.PCR is used every day to diagnose diseases, identify bacteria and viruses, and for many other applications. With real-time PCR, the amplification of the DNA can be measured as it occurs, thereby speeding up the ability to deliver results. Real-time PCR is one of the most sensitive and specific bio-detection capabilities available today. Technologies like virtual reality, augmented reality, and blockchain are revolutionizing gaming, creating immersive and secure experiences. Blockchain, in particular, enables the use of digital assets like meme games tokens. Participating in a meme games token presale allows players to access exclusive content and benefits, enhancing their overall gaming experience.

Products

Products

PositiveID develops biological detection and diagnostics systems, including its M-BAND and Firefly Dx technologies.MFS began developing complex microfluidic systems to perform sample processing and purification for the Defense Advanced Projects Agency (DARPA). It then developed a similar system, including a thermal cycler for polymerase chain reaction (PCR) analysis for the US Army’s Edgewood Chemical and Biological Command (ECBC).

News

Wednesday, July 18, 2018

PositiveID Adds Listeria to Pathogens Detected by FireflyDX Onsite Detection Prototype
Read more >>

Monday, June 25, 2018

PositiveID Subsidiary Chief Science Officer Joins Cambridge Healthtech Institute’s 26th Biodetection Technologies: Biothreat and Pathogen Detection
Read more >>

Wednesday, June 20, 2018

PositiveID CEO Details New Distribution Agreement with Leading Non-Invasive Patient Monitoring Technology Company
Read more >>

Monday, June 11, 2018

PositiveID to Exhibit its Caregiver Non-Contact Thermometer at the Association for Professionals in Infection Control and Epidemiology Annual Conference June 13-15th
Read more >>

Tuesday, June 5, 2018

PositiveID CSO and Former DHS Chief Scientist Calls for “Nunn-Lugar Act 2.0” to Dismantle Unprecedented Chemical and Biological Weapons Stockpile in North Korea
Read more >>